[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 49, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 69, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 45, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 60, "title": "Senior Vice President of Information Technology & Chief People Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 68, "title": "Interim Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi Pharm.D.", "age": 42, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew William Davis M.D., R.Ph.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.25, "open": 3.25, "dayLow": 3.23, "dayHigh": 3.38, "regularMarketPreviousClose": 3.25, "regularMarketOpen": 3.25, "regularMarketDayLow": 3.23, "regularMarketDayHigh": 3.38, "payoutRatio": 0.0, "beta": 1.655, "forwardPE": -7.280899, "volume": 2581285, "regularMarketVolume": 2581285, "averageVolume": 3827501, "averageVolume10days": 9970310, "averageDailyVolume10Day": 9970310, "bid": 3.22, "ask": 3.26, "bidSize": 56, "askSize": 14, "marketCap": 395290080, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 7.55, "allTimeHigh": 20.696, "allTimeLow": 0.618, "priceToSalesTrailing12Months": 9.108696, "fiftyDayAverage": 5.5566, "twoHundredDayAverage": 4.521725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 307603072, "profitMargins": -1.58949, "floatShares": 111904915, "sharesOutstanding": 122003113, "sharesShort": 24139081, "sharesShortPriorMonth": 19825552, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.19790001, "heldPercentInsiders": 0.03258, "heldPercentInstitutions": 0.57492, "shortRatio": 10.62, "shortPercentOfFloat": 0.22690001, "impliedSharesOutstanding": 122003113, "bookValue": -0.034, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -68979000, "trailingEps": -0.7, "forwardEps": -0.445, "enterpriseToRevenue": 7.088, "enterpriseToEbitda": -5.572, "52WeekChange": 0.0869565, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 3.24, "targetHighPrice": 12.0, "targetLowPrice": 7.0, "targetMeanPrice": 8.625, "targetMedianPrice": 8.0, "recommendationMean": 1.125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 129063000, "totalCashPerShare": 1.058, "ebitda": -55203000, "totalDebt": 41376000, "quickRatio": 5.508, "currentRatio": 5.931, "totalRevenue": 43397000, "revenuePerShare": 0.437, "returnOnAssets": -0.25496998, "grossProfits": 26158000, "freeCashflow": -25766250, "operatingCashflow": -50452000, "revenueGrowth": -0.054, "grossMargins": 0.60276, "ebitdaMargins": -1.27205, "operatingMargins": -0.89631, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "earningsTimestamp": 1762376400, "earningsTimestampStart": 1762376400, "earningsTimestampEnd": 1762376400, "earningsCallTimestampStart": 1762434000, "earningsCallTimestampEnd": 1762434000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.7, "epsForward": -0.445, "epsCurrentYear": -0.57, "priceEpsCurrentYear": -5.684211, "fiftyDayAverageChange": -2.3166, "fiftyDayAverageChangePercent": -0.41690964, "twoHundredDayAverageChange": -1.2817252, "twoHundredDayAverageChangePercent": -0.28345934, "priceToBook": -95.29411, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": 1.5432084, "postMarketPrice": 3.29, "postMarketChange": 0.049999952, "regularMarketChange": -0.00999999, "regularMarketDayRange": "3.23 - 3.38", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3827501, "fiftyTwoWeekLowChange": 1.1200001, "fiftyTwoWeekLowChangePercent": 0.52830195, "fiftyTwoWeekRange": "2.12 - 7.55", "fiftyTwoWeekHighChange": -4.3100004, "fiftyTwoWeekHighChangePercent": -0.570861, "fiftyTwoWeekChangePercent": 8.69565, "corporateActions": [], "postMarketTime": 1769215877, "regularMarketTime": 1769202001, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.307692, "regularMarketPrice": 3.24, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]